IO Biotech
IOBT
IOBT
19 hedge funds and large institutions have $41.7M invested in IO Biotech in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.54% more ownership
Funds ownership: 42.49% → 45.03% (+2.5%)
Holders
19
Holding in Top 10
–
Calls
$1.39M
Puts
–
Top Buyers
| 1 | +$4.45M | |
| 2 | +$3.71M | |
| 3 | +$3.48M | |
| 4 |
AC
Armistice Capital
New York
|
+$3.03M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.91M |
Top Sellers
| 1 | -$85.5K | |
| 2 | -$85.5K | |
| 3 | -$73.9K | |
| 4 |
Renaissance Technologies
New York
|
-$62.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$25.5K |